Opko Health, Inc.

311 articles about Opko Health, Inc.

• Opko Health Letter To Shareholders

  8/26/2015

• Opko Health Lab Signs Contracts With Leading Preferred Provider Networks For Laboratory Testing Services Including The 4Kscore Test

  8/20/2015

• Opko Health Completes Acquisition Of BioReference

  8/20/2015

• Opko Health Release: Two Reports On hGH-CTP Pediatric Phase 2 Clinical Data Accepted For Oral Presentation At The 54th Annual Meeting Of The European Society For Paediatric Endocrinology (ESPE Conference)

  8/6/2015

• Opko Health Announces Second Quarter Operating And Financial Results

  8/6/2015

• FDA Accepts Opko Health's New Drug Application For Rayaldee

  7/29/2015

• Opko Health Announces Completion Of Enrollment In Phase III Trial Of Hgh-CTP In Growth Hormone Deficient Adults

  7/10/2015

• Opko Health Investee Scivac Announces The Completion Of Transaction With Levon Resources

  7/10/2015

• Conversion Right Extended On Opko Health 3.0% Convertible Senior Notes

  7/1/2015

• Opko Health 4Kscore Recommended In National Comprehensive Cancer Network Guidelines For Prostate Cancer Early Detection

  6/29/2015

• Opko Health To Present New Data At International Society On Thrombosis And Haemostasis (ISTH) 2015 Congress On Its Long-Acting Clotting Factor VIIa

  6/10/2015

• Opko Health To Present New Data At International Society On Thrombosis And Haemostasis (ISTH) 2015 Congress On Its Long-Acting Clotting Factor VIIa

  6/9/2015

• Opko Health And Bio-Reference Laboratories To Hold Joint Conference Call To Discuss Merger

  6/8/2015

• Opko Health Lays Down $1.47 Billion for BioReference

  6/4/2015

• Opko Health Announces Submission of Rayaldee New Drug Application To FDA

  6/1/2015

• Opko Health Announces 4Kscore Abstracts At The 2015 American Urological Association Annual Meeting

  5/18/2015

• Opko Health Announces Publication Of Study Using Kallikrein Biomarkers Of The 4Kscore Test In A Large Community-Based Referral Cohort

  5/15/2015

• Opko Health Announces First Quarter Operating And Financial Results

  5/12/2015

• Opko Health Snaps Up EirGen for $135 Million

  5/7/2015

• Conversion Right Triggered On Opko Health, Inc. 3.0% Convertible Senior Notes

  4/2/2015